Association study of the HTR2A polymorphisms with efficacy and safety of risperidone or paliperidone in Chinese schizophrenic patients

DU Bo,LIU Yong-qiao,LIU Fei-hu,XIAO Wei-dong,LU Tian-lan,LI Ling-zhi,HUANG Lan,MI Wei-feng,ZHANG Hong-yan

DOI: https://doi.org/10.3969/j.issn.1001-6821.2011.06.006

2011-01-01

Abstract:Objective To study the relationship between gene polymorphisms of 5-hydroxytryptamine receptor 2A(HTR2A) genes and the clinical efficacy and safety in Han Chinese schizophrenic patients who were treated with risperidone or paliperidone.Methods Two hundreds and one schizophrenic patients were included in this study,one hundred and thirty thee inpatients or outpatients were randomized to take paliperidone palmitate(50-150 mg/4 week) or risperidone LAI(25-50 mg/2 week) for 12 weeks′ therapy,efficacy and safety examines were taken at every visit.Sixty eight inpatients or outpatients who were treated with risperidone tablets(2-6 mg·d-1) for 4 weeks were chosen.Efficacy and security examines was taken by every week.The main effect assessment was the final and baseline positive and negative syndrome scale(PANSS) total score reduced rate.The trial had chosen 3 SNPs,genotypes were detected by PCR-RFLP or direct sequencing.Results For clinical efficacy,it seemed that the genotypes of rs7997012 was associated with the clinical efficacy(P<0.05).There was no association between rs6313,rs6311 genotypes and clinical efficacy(P>0.05).As to the analysis between gene polymorphism and drug treatment safety,rs6313 and rs6311 genotypes might have influences on the BARS,SAS rating increase(P<0.05),and also rs6313 and rs6311 genotypes might be associated with the increasing level of AST and ALT(P<0.05).Conclusion The result give a possible association between HTR2A gene polymorphisms and the clinical efficacy or safety in Han Chinese schizophrenia patients treated with risperidone or paliperidone,which may be a guide for the individualized treatment of schizophrenia patients.